Literature DB >> 20616729

Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations.

Mandy L Ford1, Christian P Larsen.   

Abstract

PURPOSE OF REVIEW: This review highlights recent advances in our understanding of the frequency and nature of alloreactivity among memory T-cell populations, and discusses recent successes in experimentally targeting these populations in order to prolong graft survival. RECENT
FINDINGS: Recent studies suggest that not only is alloreactivity present within peripheral T-cell compartments of normal healthy individuals, but cross-reactivity between viral-specific T cells and allotropes may in fact be a very common occurrence. Furthermore, this cross-reactivity functions at the level of molecular mimicry of T-cell receptor recognition. Therapeutics that specifically target cell surface molecules or effector pathways used by memory T cells to mediate graft rejection will likely be required in order to attenuate the donor-reactive memory T-cell response during transplantation.
SUMMARY: A major challenge facing the field over the next decade is to define the heterogeneity that exists within memory T-cell populations that impacts graft survival. Understanding the functional and phenotypic differences that modify the memory T-cell barrier to tolerance induction might allow a strategy in which strength of immunosuppression could be tailored to fit the immunological history of a given transplant recipient in order to minimize nonimmune toxicities, maximize protective immunity, and prolong graft survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616729      PMCID: PMC4642449          DOI: 10.1097/MOT.0b013e32833b7916

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  41 in total

1.  Homeostatic proliferation is a barrier to transplantation tolerance.

Authors:  Zihao Wu; Steven J Bensinger; Jidong Zhang; Chuangqi Chen; Xueli Yuan; Xiaolun Huang; James F Markmann; Alireza Kassaee; Bruce R Rosengard; Wayne W Hancock; Mohamed H Sayegh; Laurence A Turka
Journal:  Nat Med       Date:  2003-11-30       Impact factor: 53.440

2.  T cell allorecognition via molecular mimicry.

Authors:  Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

3.  Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates.

Authors:  Jung-Sik Kim; Jae-Il Lee; Jin-Young Shin; Su-Young Kim; Jun-Seop Shin; Jong-Hyung Lim; Hyoung-Soo Cho; Il-Hee Yoon; Ki-Hyun Kim; Sang-Joon Kim; Chung-Gyu Park
Journal:  Transplantation       Date:  2009-12-27       Impact factor: 4.939

4.  A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

Authors:  F Vincenti; B Charpentier; Y Vanrenterghem; L Rostaing; B Bresnahan; P Darji; P Massari; G A Mondragon-Ramirez; M Agarwal; G Di Russo; C-S Lin; P Garg; C P Larsen
Journal:  Am J Transplant       Date:  2010-03       Impact factor: 8.086

Review 5.  Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction.

Authors:  Mandy L Ford; Allan D Kirk; Christian P Larsen
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

Review 6.  Heterologous immunity: an overlooked barrier to tolerance.

Authors:  Andrew B Adams; Thomas C Pearson; Christian P Larsen
Journal:  Immunol Rev       Date:  2003-12       Impact factor: 12.988

7.  Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptor.

Authors:  Travis Beddoe; Zhenjun Chen; Craig S Clements; Lauren K Ely; Simon R Bushell; Julian P Vivian; Lars Kjer-Nielsen; Siew Siew Pang; Michelle A Dunstone; Yu Chih Liu; Whitney A Macdonald; Matthew A Perugini; Matthew C J Wilce; Scott R Burrows; Anthony W Purcell; Tony Tiganis; Stephen P Bottomley; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2009-05-21       Impact factor: 31.745

8.  Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.

Authors:  Tim A Weaver; Ali H Charafeddine; Avinash Agarwal; Alexandra P Turner; Maria Russell; Frank V Leopardi; Robert L Kampen; Linda Stempora; Mingqing Song; Christian P Larsen; Allan D Kirk
Journal:  Nat Med       Date:  2009-07-05       Impact factor: 53.440

9.  Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity.

Authors:  Luzheng Liu; Qiong Zhong; Tian Tian; Krista Dubin; Shruti K Athale; Thomas S Kupper
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

10.  Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.

Authors:  Elisabeth Amyes; Chris Hatton; Damien Montamat-Sicotte; Nancy Gudgeon; Alan B Rickinson; Andrew J McMichael; Margaret F C Callan
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  27 in total

1.  Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.

Authors:  A D Kirk; A Guasch; H Xu; J Cheeseman; S I Mead; A Ghali; A K Mehta; D Wu; H Gebel; R Bray; J Horan; L S Kean; C P Larsen; T C Pearson
Journal:  Am J Transplant       Date:  2014-03-31       Impact factor: 8.086

2.  Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity.

Authors:  Scott M Krummey; Ryan J Martinez; Rakieb Andargachew; Danya Liu; Maylene Wagener; Jacob E Kohlmeier; Brian D Evavold; Christian P Larsen; Mandy L Ford
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

3.  Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.

Authors:  Mohamed B Ezzelarab; Lien Lu; Hao Guo; Alan F Zahorchak; William F Shufesky; David K C Cooper; Adrian E Morelli; Angus W Thomson
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

4.  Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys.

Authors:  M R L Marco; E M Dons; D J van der Windt; J K Bhama; L T Lu; A F Zahorchak; F G Lakkis; D K C Cooper; M B Ezzelarab; A W Thomson
Journal:  Transpl Immunol       Date:  2013-10-09       Impact factor: 1.708

5.  Antigen-Specificity of T Cell Infiltrates in Biopsies With T Cell-Mediated Rejection and BK Polyomavirus Viremia: Analysis by Next Generation Sequencing.

Authors:  G Zeng; Y Huang; Y Huang; Z Lyu; D Lesniak; P Randhawa
Journal:  Am J Transplant       Date:  2016-07-15       Impact factor: 8.086

Review 6.  Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Expert Opin Biol Ther       Date:  2017-05-30       Impact factor: 4.388

7.  IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.

Authors:  O Traitanon; A Gorbachev; J J Bechtel; K S Keslar; W M Baldwin; E D Poggio; R L Fairchild
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

Review 8.  Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

Authors:  Seema R Patel; James C Zimring
Journal:  Transfus Med Rev       Date:  2013-10-03

Review 9.  T Cell Cosignaling Molecules in Transplantation.

Authors:  Mandy L Ford
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Allograft outcomes in outbred mice.

Authors:  D K Reichenbach; Q Li; R A Hoffman; A L Williams; W D Shlomchik; D M Rothstein; A J Demetris; F G Lakkis
Journal:  Am J Transplant       Date:  2013-01-11       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.